Literature DB >> 25104599

Causes of vision loss worldwide, 1990-2010: a systematic analysis.

Rupert R A Bourne1, Gretchen A Stevens2, Richard A White3, Jennifer L Smith4, Seth R Flaxman5, Holly Price6, Jost B Jonas7, Jill Keeffe8, Janet Leasher9, Kovin Naidoo10, Konrad Pesudovs11, Serge Resnikoff12, Hugh R Taylor13.   

Abstract

BACKGROUND: Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking.
METHODS: We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990-2010 by age, geographical region, and year.
FINDINGS: In 2010, 65% (95% uncertainty interval [UI] 61-68) of 32·4 million blind people and 76% (73-79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65-70) of 31·8 million and 80% (78-83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration.
INTERPRETATION: The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care. FUNDING: Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute.
Copyright © 2013 Bourne et al. Open Access article distributed under the terms of CC BY. Published by .. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 25104599     DOI: 10.1016/S2214-109X(13)70113-X

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  451 in total

1.  The Royal College of Ophthalmologists' Cataract Surgery Commissioning Guidance: executive summary.

Authors:  A C Day; R Wormald; S Coronini-Cronberg; R Smith
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

Review 2.  Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure.

Authors:  Jost B Jonas; Liang Xu; Jie Xu; Wen Bin Wei; Ya Xing Wang
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 3.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

4.  Association of Cataract Surgery With Traffic Crashes.

Authors:  Matthew B Schlenker; Deva Thiruchelvam; Donald A Redelmeier
Journal:  JAMA Ophthalmol       Date:  2018-09-01       Impact factor: 7.389

5.  Predictors of visual and anatomical outcomes for neovascular age-related macular degeneration treated with bevacizumab.

Authors:  Chaoran Ma; Liang Bai; Chunling Lei; Changrui Wu; Qiang Shi; Feng Hu; Zhenxuan Hao; L E Ma
Journal:  Biomed Rep       Date:  2015-04-16

Review 6.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

7.  Simulation and analysis of light scattering by multilamellar bodies present in the human eye.

Authors:  Emilia M Méndez-Aguilar; Ismael Kelly-Pérez; L R Berriel-Valdos; José A Delgado-Atencio
Journal:  Biomed Opt Express       Date:  2017-05-19       Impact factor: 3.732

8.  Trends in ophthalmology journals: a five-year bibliometric analysis (2009-2013).

Authors:  Christopher B Schulz; Alasdair Kennedy; Ben C Rymer
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

9.  Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy.

Authors:  Jiong Hu; Sarah Dziumbla; Jihong Lin; Sofia-Iris Bibli; Sven Zukunft; Julian de Mos; Khader Awwad; Timo Frömel; Andreas Jungmann; Kavi Devraj; Zhixing Cheng; Liya Wang; Sascha Fauser; Charles G Eberhart; Akrit Sodhi; Bruce D Hammock; Stefan Liebner; Oliver J Müller; Clemens Glaubitz; Hans-Peter Hammes; Rüdiger Popp; Ingrid Fleming
Journal:  Nature       Date:  2017-12-06       Impact factor: 49.962

10.  Predictors of Spectacle Wear and Reasons for Nonwear in Students Randomized to Ready-made or Custom-made Spectacles: Results of Secondary Objectives From a Randomized Noninferiority Trial.

Authors:  Priya Morjaria; Jennifer Evans; Clare Gilbert
Journal:  JAMA Ophthalmol       Date:  2019-04-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.